Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aldrich Richard
Relationship:   Director
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   444,838    

Indirect Shares

   12,959,539      
Direct Value   $4,957,302    

Indirect Value

   $86,989,948      
Total Shares   13,404,377      
Total Value   $91,947,249      


Altus Pharmaceuticals Inc. $0 Verastem, Inc. $4,950,762 Tempest Therapeutics, Inc $6,539 Altus Pharmaceuticals Inc. $0 Verastem, Inc. $4,950,762 Tempest Therapeutics, Inc $6,539
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   81.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Altus Pharmaceuticals Inc. ALTUQ Director 2006-01-25 30,527 0    Premium*  
            Lipid Sciences Inc LIPD 10% Owner 2006-12-21 0 2006-12-21 3,662,662    Premium*  
            Sequenom Inc SQNM 10% Owner 2008-06-06 0 2008-06-25 5,853,697    Premium*  
            Aradigm Corp ARDM 10% Owner 2008-10-29 0 2008-10-29 1,081,410    Premium*  
            Biospecifics Technologies Corp BSTC 10% Owner 2008-10-30 0 2008-11-14 697,309    Premium*  
            Verastem, Inc. VSTM Director 2014-05-20 408,142 2014-05-20 299,294    Premium*  
            Tempest Therapeutics, Inc TPST Director 2018-12-07 6,169 2018-12-07 130,683    Premium*  
            PTC Therapeutics, Inc. PTCT Director 2015-06-08 0 2013-06-25 300,000    Premium*  
            Concert Pharmaceuticals, Inc. CNCE Director 2023-03-06 0 2023-03-06 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director 2016-11-21 0 2017-10-12 934,484    Premium*  
* Premium Members only  

Records found :    141         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALTUQ Altus Pharmaceuticals Inc... officerTitle   –       •      –    2006-01-25 3 IO $0.00 $0 D/D 0 30,527 -
ARDM Aradigm Corp 10% Owner   –       –       •   2008-10-29 4 S $0.25 $1,400,000 I/I (5,600,000) 1,081,410 0 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-10-30 4 B $14.00 $14,000 I/I 1,000 637,444 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-10-31 4 B $13.50 $144,540 I/I 10,000 647,444 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-11-03 4 B $15.00 $13,700 I/I 900 648,344 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-11-05 4 B $16.00 $8,000 I/I 500 648,844 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-11-12 4 B $15.00 $154,440 I/I 10,000 658,844 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-11-13 4 B $15.00 $403,752 I/I 24,165 683,009 1.5 -
BSTC Biospecifics Technologies... 10% Owner   –       –       •   2008-11-14 4 B $15.75 $235,450 I/I 14,300 697,309 1.5 -
CNCE Concert Pharmaceuticals, ... Director   –       •       •   2014-02-12 3 IO $0.00 $0 D/D 0 286,963 -
CNCE Concert Pharmaceuticals, ... Director   –       •       •   2014-02-12 3 IO $0.00 $0 I/I 0 102,417 -
CNCE Concert Pharmaceuticals, ... Director   –       •       •   2014-02-19 4 A $0.00 $0 I/I 61,946 61,946 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2014-10-16 4 GA $0.00 $0 I/I 82,405 82,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2014-10-16 4 GD $0.00 $0 I/I 102,417 0 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2014-10-16 4 GA $0.00 $0 D/D 20,012 306,975 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2015-08-26 4 GA $0.00 $0 I/I 82,405 82,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2015-08-26 4 GD $0.00 $0 I/I 82,405 0 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2015-12-16 4 AS $19.76 $395,190 D/D (20,000) 286,975 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 AS $19.26 $192,650 I/I (10,000) 77,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 AS $19.08 $405,183 D/D (21,236) 286,975 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 OE $2.88 $77,405 D/D 21,236 308,211 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-17 4 AS $18.95 $189,900 I/I (10,000) 72,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-18 4 AS $19.36 $193,950 I/I (10,000) 67,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-19 4 AS $19.65 $196,550 I/I (10,000) 62,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-22 4 AS $19.54 $195,450 I/I (10,000) 57,405 0 -
  141  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us